ProBioGen Overview

  • Founded
  • 1994

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 250

Employees
  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 3

ProBioGen General Information

Description

Provider of contract development and manufacturing services in the field of line engineering, process development and GMP manufacturing of biopharmaceuticals. The company's range of services include production cell line engineering, including media optimization, upstream and downstream process development and analytical services, including sophisticated cell-based bioassays.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Other Commercial Services
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • Goethestrasse 54
  • 13086 Berlin
  • Germany
+49 030 0000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProBioGen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ProBioGen‘s full profile, request access.

Request a free trial

ProBioGen Patents

ProBioGen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220090142-A1 Transposase with enhanced insertion site selection properties Pending 13-Feb-2019 000000000
EP-3924474-A1 Transposase with enhanced insertion site selection properties Pending 13-Feb-2019 000000000
CA-3126773-A1 Transposase with enhanced insertion site selection properties Pending 13-Feb-2019 000000000
AU-2019429609-A1 Transposase with enhanced insertion site selection properties Pending 13-Feb-2019 000000000
JP-2022523166-A Transposase with improved insertion site selection characteristics Pending 13-Feb-2019 C12N15/90
To view ProBioGen’s complete patent history, request access »

ProBioGen Executive Team (5)

Name Title Board Seat Contact Info
Lutz Hilbrich Chief Executive Officer
Volker Sandig Ph.D Chief Scientific Officer
Gabriele Schneider Chief Business Officer
You’re viewing 3 of 5 executive team members. Get the full list »

ProBioGen Board Members (2)

Name Representing Role Since
00000 00000000 Minapharm Pharmaceuticals Chairman 000 0000
You’re viewing 1 of 2 board members. Get the full list »

ProBioGen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProBioGen Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ProBioGen‘s full profile, request access.

Request a free trial